CD38, an NAD+-hydrolyzing ectoenzyme and marker of immune cell activation13, is upregulated in SLE T cells compared to healthy controls, and its expression correlates with disease activity14,15. This evidence concerns the gene CD38 and systemic lupus erythematosus.